Business
NEUPATH HEALTH ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AS PART OF PLANNED TRANSITION, PRE-ANNOUNCES STRONG 2025 RESULTS
TORONTO, January 26, 2026--NeuPath Health Inc. (TSXV:NPTH) (NeuPath or the "Company") today announced the timing and details for a planned leadership transition in 2026, as well as preliminary revenue and Adjusted EBITDA expectations for 2025. As part of its long-term succession planning, NeuPath’s President Stephen Lemieux will succeed Joseph Walewicz as Chief Executive Officer effective April 1, 2026. Joseph will continue his role on the Board of Directors and work closely with NeuPath’s leade
About this update from Neupath Health Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":200,"url":"https://media.zenfs.com/en/business-wire.com/453434212b05fcdec716d8caaa4a2c45"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/N3g8N3iZ0QAiBg669GdqfA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQwMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/453434212b05fcdec716d8caaa4a2c45","width":480,"height":200}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"As part of a planned transition, Stephen Lemieux will succeed Joseph Walewicz as Chief Executive Officer effective April 1, 2026. Joseph Walewicz will continue as a member of NeuPath’s Board of Directors and in a consulting capacity, providing continuity and ongoing strategic guidance to the leadership team.","length":309,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Sandee Dela Cruz has been promoted to the new role of Chief Information Officer and has joined NeuPath’s executive leadership team to guide IT strategy in support of growth initiatives.","length":185,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Preliminary 2025 revenues of between $86 million and $88 million, with Adjusted EBITDA(1) expected to be in the range of $5.6 million to $6.0 million for the 2025. Audited year-end results are expected to be announced on March 26, 2026.","length":236,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":730,"olType":false},{"type":"text","content":"TORONTO, January 26, 2026--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH) (NeuPath or the "Company") today announced the timing and details for a planned leadership transition in 2026, as well as preliminary revenue and Adjusted EBITDA expectations for 2025. As part of its long-term succession planning, NeuPath’s President Stephen Lemieux will succeed Joseph Walewicz as Chief Executive Officer effective April 1, 2026. Joseph will continue his role on the Board of Directors and work closely with NeuPath’s leadership team to support NeuPath’s growth initiatives. The Company also announced the promotion of Sandee Dela Cruz to the new position of Chief Information Officer effective January 1, 2026.","length":715,"tagName":"p"},{"type":"text","content":"Stephen returned to NeuPath as Presid...